Clay Siegall made Seattle Genetic be one of the best organizations in the world through the services that they provide. In addition, he is the CEO and the president of the company. His determination is also the reason behind the success of the organization. He also spares his time in supporting other needy people in the society hence he is a well-known philanthropist. His transformation in the business sector enabled him to develop Seattle Genetic. He went to George Washington University and got Ph.D. in genetics and the University of Maryland in B.S in Zoology. Most of the work that he had done had been recognized and awarded various time including from Maryland University award in natural sciences, math and computer of Alumnus in the year 2013.
Seattle Genetic success is due to biotechnology it enables the organization to create better strategies that enable the organization to provide better services to their clients. Many clinics in the world are very pleased with the medical strategies that they attain hence they are able to help their patient. Furthermore antibody drug conjugate (ADC) is one of the accomplishments that the organization introduced due to the partnership of different organization hence they were able to make more profit. Cancer patients are also happy and they encourage Seattle Genetics to always come up with best strategies in the future in order to get better treatment. Also, Adcentric has been delivered in all part of the world. Settle Genetic also ensure that their staff members are well trained so they can serve their clients with better services. Due to the income that the organization accomplishes they pay their workers better salary hence these also motivates them to work hard.
Seattle Genetics made over $330 since the company started and also have delivered 20 ADCs to more than clinics all over the world. The organization also ensures that the staff members always are in good terms all the time so they can do their daily activity. Also in the future, the organization are certain that they will introduce better therapies that will treat cancer patients.